Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Return on Assets: 2010-2025

Historic Return on Assets for China Pharma Holdings (CPHI) over the last 15 years, with Sep 2025 value amounting to -0.22%.

  • China Pharma Holdings' Return on Assets rose 13.00% to -0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.22%, marking a year-over-year increase of 13.00%. This contributed to the annual value of -0.30% for FY2024, which is 12.00% down from last year.
  • Latest data reveals that China Pharma Holdings reported Return on Assets of -0.22% as of Q3 2025, which was up 17.44% from -0.26% recorded in Q2 2025.
  • China Pharma Holdings' Return on Assets' 5-year high stood at -0.15% during Q1 2021, with a 5-year trough of -0.34% in Q3 2024.
  • Over the past 3 years, China Pharma Holdings' median Return on Assets value was -0.22% (recorded in 2024), while the average stood at -0.25%.
  • As far as peak fluctuations go, China Pharma Holdings' Return on Assets skyrocketed by 79bps in 2021, and later decreased by 14bps in 2024.
  • China Pharma Holdings' Return on Assets (Quarterly) stood at -0.17% in 2021, then dropped by 7bps to -0.23% in 2022, then climbed by 4bps to -0.19% in 2023, then fell by 14bps to -0.33% in 2024, then rose by 13bps to -0.22% in 2025.
  • Its Return on Assets was -0.22% in Q3 2025, compared to -0.26% in Q2 2025 and -0.31% in Q1 2025.